Status:

UNKNOWN

Machine-learning Algorithm to Differentiate Intraoperative Ketamine Dosing Based on Electroencephalographic Density Spectrum Array Analysis

Lead Sponsor:

Taipei Veterans General Hospital, Taiwan

Conditions:

Electroencephalographic Density Spectrum Array Analysis

Density Spectrum Array

Eligibility:

All Genders

20-80 years

Brief Summary

Ketamine is widely used in the setting of multimodal general anesthesia, and the Electroencephalographic density spectral array (DSA) monitoring has been implemented in the practice of anesthesia. The...

Detailed Description

In this single-blinded randomized controlled trial, we enroll 90 patients undergoing major spine surgery, and candidates are divided into 3 groups: A (control group using sevoflurane only), B (sevoflu...

Eligibility Criteria

Inclusion

  • Patients undergoing elective spine surgery
  • Aged 20-80 years old

Exclusion

  • Pregnancy
  • Presence of major brain disorders: stroke, epilepsy, Parkinson's disease, etc.
  • Any of the following major organ disorders:
  • Chronic pulmonary disease (Clinically diagnosed severe chronic obstructive pulmonary disease or FEV1/FVC \<70% or FEV1 \<50%)
  • Heart failure (NYHA III or IV)
  • Chronic renal failure (eGFR\<60ml/min/1.73m2)
  • Ongoing sepsis or infection
  • Ongoing of history of CNS-acting medications/substances use (e.g.: sedatives, hypnotics, stimulants, etc.)

Key Trial Info

Start Date :

March 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2022

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT05256264

Start Date

March 1 2022

End Date

December 31 2022

Last Update

August 17 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Taipei Veterans General Hospital

Taipei, Beitou, Taiwan, 112